| Sean Thoreby, OD | |
|
10002 Se 240th St, Kent, WA 98031-4839 | |
| (253) 852-2020 | |
| (253) 854-2020 |
| Full Name | Sean Thoreby |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 10002 Se 240th St, Kent, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164776282 | NPI | - | NPPES |
| G8944042 | Other | WA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD60570238 (Washington) | Primary |
| Provider Name | Kosnoski Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003995747 PECOS PAC ID: 7618978859 Enrollment ID: O20070130000741 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
A program designed by University at Buffalo researchers to increase mathematics achievement in pre-kindergarten students has proven successful in a large-scale study in Buffalo and Boston.
In other news, Partners HealthCare hopes to replace its patchwork approach to electronic health records with a single commercial system.
Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 8 days ago
| Provider Name | Clear Sight Northwest, Ps |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1740558642 PECOS PAC ID: 5193982536 Enrollment ID: O20120213000665 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
A program designed by University at Buffalo researchers to increase mathematics achievement in pre-kindergarten students has proven successful in a large-scale study in Buffalo and Boston.
In other news, Partners HealthCare hopes to replace its patchwork approach to electronic health records with a single commercial system.
Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 8 days ago
| Provider Name | Aeg Washington Professional Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1134835176 PECOS PAC ID: 3476927997 Enrollment ID: O20230324001321 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
A program designed by University at Buffalo researchers to increase mathematics achievement in pre-kindergarten students has proven successful in a large-scale study in Buffalo and Boston.
In other news, Partners HealthCare hopes to replace its patchwork approach to electronic health records with a single commercial system.
Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Thoreby, OD 10002 Se 240th St, Kent, WA 98031-4839 Ph: (253) 852-2020 | Sean Thoreby, OD 10002 Se 240th St, Kent, WA 98031-4839 Ph: (253) 852-2020 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
A program designed by University at Buffalo researchers to increase mathematics achievement in pre-kindergarten students has proven successful in a large-scale study in Buffalo and Boston.
In other news, Partners HealthCare hopes to replace its patchwork approach to electronic health records with a single commercial system.
Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.
› Verified 8 days ago
Kosnoski Eye Care Inc Optometrist Medicare: Medicare Enrolled Practice Location: 10002 Se 240th St, Kent, WA 98031 Phone: 253-852-2020 Fax: 253-854-2020 | |
Seth Bruinsma, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10002 Se 240th St, Kent, WA 98031 Phone: 253-852-2020 Fax: 253-854-2020 | |
East Hill Optometry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11120 Se Kent Kangley Rd, Kent, WA 98030 Phone: 253-859-0942 | |
Dr. Bryan J. Heitmeyer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8009 S 180th St Ste 104, Kent, WA 98032 Phone: 425-251-9200 Fax: 425-251-9201 | |
Dr. Yen Duong, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10002 Se 240th St, Kent, WA 98031 Phone: 253-852-2020 | |
Dr. Jonathan Nguyen Dong, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 10725 Se 256th St Ste 4, Kent, WA 98030 Phone: 253-201-2515 Fax: 253-479-0104 | |
Edward Lawrence Jones & Assoc Optometrist Medicare: Medicare Enrolled Practice Location: 601 W Gowe St, Kent, WA 98032 Phone: 253-854-2028 Fax: 253-854-2744 |